🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Lumos Pharma Inc (LUMO)

NASDAQ
Currency in USD
Disclaimer
3.930
+0.200(+5.36%)
Closed
LUMO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
3.6003.930
52 wk Range
1.3704.550
Prev. Close
3.73
Open
3.81
Day's Range
3.6-3.93
52 wk Range
1.37-4.55
Volume
31,291
Average Volume (3m)
78,650
1-Year Change
20.18%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
LUMO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
21.750
Upside
+453.435%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Lumos Pharma Inc Company Profile

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases. Its primary product candidate is LUM-201, an oral growth hormone secretagogue ibutamoren, which is in Phase III clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company has a clinical collaboration with Massachusetts General Hospital to evaluate oral LUM-201 in nonalcoholic fatty liver disease. Lumos Pharma, Inc. is headquartered in Austin, Texas.

Compare LUMO to Peers and Sector

Metrics to compare
LUMO
Peers
Sector
Relationship
P/E Ratio
−0.9x−1.3x−0.6x
PEG Ratio
0.060.000.00
Price/Book
3.1x−2.0x2.6x
Price / LTM Sales
21.5x3.3x3.1x
Upside (Analyst Target)
485.2%139.6%55.7%
Fair Value Upside
Unlock−16.9%6.9%Unlock

FAQ

What Is the Lumos Pharma Inc (LUMO) Stock Price Today?

The Lumos Pharma Inc stock price today is 3.93

What Stock Exchange Does Lumos Pharma Inc Trade On?

Lumos Pharma Inc is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Lumos Pharma Inc?

The stock symbol for Lumos Pharma Inc is "LUMO."

What Is the Lumos Pharma Inc Market Cap?

As of today, Lumos Pharma Inc market cap is 31.93M.

What is Lumos Pharma Inc Earnings Per Share?

The Lumos Pharma Inc EPS is -4.42.

What Is the Next Lumos Pharma Inc Earnings Date?

Lumos Pharma Inc will release its next earnings report on 11 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.